Topic
Sglt2
Recent coverage of Sglt2 from across the web.
-
Advanced age does not limit the benefits of sodium-glucose cotransporter 2 inhibitors in chronic kidney disease -
Popular diabetes drug shown to lower inflammation, which may protect the heart -
Lower dementia risk seen with sodium-glucose cotransporter 2 in seniors 65+ with mood, psychotic disorders
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow